Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8408275rdf:typepubmed:Citationlld:pubmed
pubmed-article:8408275lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C0041455lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C1440080lld:lifeskim
pubmed-article:8408275lifeskim:mentionsumls-concept:C0038891lld:lifeskim
pubmed-article:8408275pubmed:dateCreated1993-11-16lld:pubmed
pubmed-article:8408275pubmed:abstractTextDuring alveolar development and alveolar repair close contacts are established between fibroblasts and lung epithelial cells through gaps in the basement membrane. Using co-culture systems we have investigated whether these close contacts influence synthesis and secretion of the principal surfactant apoprotein (SP-A) by cultured rat lung alveolar type II cells and the synthesis and secretion of type I collagen by fibroblasts. The alveolar type II cells remained cuboidal and grew in colonies on fibroblast feeder layers and on Matrigel-coated cell culture inserts but were progressively more flattened on fixed fibroblast monolayers and plastic. Alveolar type II cells cultured on plastic released almost all their SP-A into the medium by 4 days. Alveolar type II cells cultured on viable fibroblasts or Matrigel-coated inserts above fibroblasts accumulated SP-A in the medium at a constant rate for the first 4 days, and probably recycle SP-A by endocytosis. The amount of mRNA for SP-A was very low after 4 days of culture of alveolar type II cells on plastic, Matrigel-coated inserts or fixed fibroblast monolayers: relatively, the amount of mRNA for SP-A was increased 4-fold after culture of alveolar type II cells on viable fibroblasts. Co-culture of alveolar type II cells with confluent human dermal fibroblasts stimulated by 2- to 3-fold the secretion of collagen type I into the culture medium, even after the fibroblasts' growth had been arrested with mitomycin C. Collagen secretion, by fibroblasts, also was stimulated 2-fold by conditioned medium from alveolar type II cells cultured on Matrigel. The amount of mRNA for type I collagen increased only modestly when fibroblasts were cultured in this conditioned medium. This stimulation of type I collagen secretion diminished as the conditioned medium was diluted out, but at high dilutions further stimulation occurred, indicating that a factor that inhibited collagen secretion also was being diluted out. The conditioned medium contained low levels of IGF-1 and the stimulation of type I collagen secretion was abolished when the conditioned medium was pre-incubated with antibodies to insulin-like growth factor 1 (IGF-1). There are important reciprocal interactions between alveolar type II cells and fibroblasts in co-culture. Direct contacts between alveolar type II cells and fibroblasts appear to have a trophic effect on cultured alveolar type II cells, increasing the levels of mRNA for SP-A. Rat lung alveolar type II cells appear to release a factor (possibly IGF-1) that stimulates type I collagen secretion by fibroblasts.lld:pubmed
pubmed-article:8408275pubmed:languageenglld:pubmed
pubmed-article:8408275pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:citationSubsetIMlld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8408275pubmed:statusMEDLINElld:pubmed
pubmed-article:8408275pubmed:monthJunlld:pubmed
pubmed-article:8408275pubmed:issn0021-9533lld:pubmed
pubmed-article:8408275pubmed:authorpubmed-author:PowellJ TJTlld:pubmed
pubmed-article:8408275pubmed:authorpubmed-author:GriffinMMlld:pubmed
pubmed-article:8408275pubmed:authorpubmed-author:ChanY CYClld:pubmed
pubmed-article:8408275pubmed:authorpubmed-author:HamiltonGGlld:pubmed
pubmed-article:8408275pubmed:authorpubmed-author:BhandariRRlld:pubmed
pubmed-article:8408275pubmed:issnTypePrintlld:pubmed
pubmed-article:8408275pubmed:volume105 ( Pt 2)lld:pubmed
pubmed-article:8408275pubmed:ownerNLMlld:pubmed
pubmed-article:8408275pubmed:authorsCompleteYlld:pubmed
pubmed-article:8408275pubmed:pagination423-32lld:pubmed
pubmed-article:8408275pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:meshHeadingpubmed-meshheading:8408275-...lld:pubmed
pubmed-article:8408275pubmed:year1993lld:pubmed
pubmed-article:8408275pubmed:articleTitleAlveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen.lld:pubmed
pubmed-article:8408275pubmed:affiliationDepartment of Biochemistry, Charing Cross and Westminister Medical School, London, UK.lld:pubmed
pubmed-article:8408275pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8408275pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8408275lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8408275lld:pubmed